SUNFLU TABLET
Pharmacy Only
Drug type: Therapeutic
ATC code: N02BE51
Dosage form: TABLET
Route of administration: ORAL
Active ingredient: PHENYLEPHRINE HCl; PARACETAMOL; CAFFEINE; CHLORPHENIRAMINE MALEATE; CAFFEINE; CHLORPHENIRAMINE MALEATE; PARACETAMOL; PHENYLEPHRINE HCl
Indications:
It is indicated for the relief of nasal congestion as well as fevers, aches, pains and general discomfort associated with colds and upper respiratory infections.
Contraindications:
It is contraindicated in patients who are hypersensitive to any of the ingredients.
Due to the component phenylephrine, it is contraindicated in patients with ventricular tachycardia or severe hypertension.
Due to the component chlorpheniramine maleate, it is contraindicated in patients on monoamine oxidase inhibitor therapy and also in lower respiratory tract infections.
Recommended dosage, dosage schedule and route of administration:
Adults: Two tablets every four hours, not to exceed 8 tablets in 24 hours.
Registrant
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Approval Date
1989-06-07
Approval Number
SIN03038P
Manufacturer
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SUNWARD PHARMACEUTICAL PRIVATE LIMITED